Ireland is set to receive over 500,000 additional doses of the BioNtech/Pfizer vaccine over the next three months as part of a wider EU agreement.
Pfizer/BioNTech is bringing forward delivery of 50 million doses to the second quarter, starting this month, and negotiations are underway with it to supply 1.8 billion doses of a second-generation of its mRNA vaccine to combat variants, European Commission chief Ursula von der Leyen announced today.
Von der Leyen said that would bring the total number of BioNTech/Pfizer doses for April, May and June to 250 million – accounting for more than half of all jabs to be given in this quarter.
“I think this will substantially help consolidate the rollout of our vaccination campaigns,” she said.
“It has proven to be a reliable partner. It has delivered on its commitments, and it is responsive to our needs.”